Description

For Research Purposes Only. Not approved for human consumption. Retatrutide Research Peptide Retatrutide is a synthetic triple hormone receptor agonist peptide developed by Eli Lilly — the first-in-class compound to simultaneously activate GLP-1, GIP, and glucagon receptors. In Phase 3 SURMOUNT tria